GLOBUS MEDICAL INC 8-K

What Happened

• Globus Medical, Inc. announced and furnished a press release on February 24, 2026 reporting its sales and operating results for the three‑month and twelve‑month periods ended December 31, 2025. The company filed this information on Form 8‑K under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: February 24, 2026 (Form 8‑K, Item 2.02).
• Periods covered: three‑month and twelve‑month periods ended December 31, 2025 (Q4 and full‑year 2025 results).
• The press release is furnished as Exhibit 99.1 to the 8‑K.
• The report was signed on behalf of the company by Kyle R. Kline, Chief Financial Officer (SVP), on February 24, 2026.

Why It Matters

• This 8‑K furnishes the company’s official sales and operating results for Q4 and full‑year 2025—key data investors use to evaluate revenue trends, profitability, and management execution.
• Investors should review the attached press release (Exhibit 99.1) for the specific revenue, operating income, margin, and any accompanying commentary or guidance that could affect near‑term stock performance and valuation.